Navigation Links
Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
Date:2/5/2013

KANSAS CITY, Kan. and BOSTON, Feb. 5, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will present at two upcoming healthcare conferences.  Steven St. Peter , M.D., President and Chief Executive Officer of Aratana Therapeutics, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with potential collaborators. 

Aratana has been selected as one of a few privately held companies to present at the 2013 BIO CEO and Investor Conference, to be held February 11-12, 2013, at the Waldorf Astoria Hotel in New York.  Event:BIO CEO and Investor ConferenceDate: Tuesday, February 12, 2013 Time: 9:45 am (Eastern Time) Location:Park South; Waldorf Astoria Hotel; New YorkThe Company will also present at the Leerink Swann Global Healthcare Conference, to be held February 13-14, 2013, also at the Waldorf Astoria Hotel.  Event:Leerink Swann Global Healthcare ConferenceDate: Thursday, February 14, 2013 Time: 2:30 pm (Eastern Time) Location:Morgan Suite; Waldorf Astoria Hotel; New YorkDr. St. Peter will be joined by Louise Mawhinney , CPA, Chief Financial Officer; Linda Rhodes , V.M.D., Ph.D., Chief Scientific Officer; Julia Stephanus , Chief Commercial Officer; and Erick Lucera , Vice President, Corporate Development of Aratana Therapeutics.About Aratana TherapeuticsAratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm , Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com 
amielach@tiberend.com


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
2. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
3. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
4. Aratana to Participate in Leerink Swanns November Management Access Days
5. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
6. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
7. Prime Therapeutics named a 2013 National Top Workplace
8. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
9. Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
10. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
11. Prime Therapeutics names Ann Tobin as Chief Compliance Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Summary This report provides all the information ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... Germany , March 27, 2017 ... over 7,000 attendees and more than 600 exhibitors ... and discover opportunities and solutions that will advance ... 6 April 2017 at the Messe Stuttgart, ... the preeminent medical technology platform showcasing the key ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... ... , ... Usually, the impending arrival of warmer weather means the gleeful banishment ... double chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic ... double chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a ... time and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service ... uses biometric face recognition to enable users to check in and out from ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder ... few medical professionals in the country to sit on the 2017 National Advisory Board ... just 2 years Dr. Harper helped propel the clinic from a small start-up to ...
(Date:3/28/2017)... ... 28, 2017 , ... The Lice Treatment Center® booth at ... was a busy spot this year. Liz Solovay and Adrian Picheny, the firm’s ... among camp communities during the upcoming 2017 camping season. “Lice infestations at some ...
Breaking Medicine News(10 mins):